StemGen (SGNI) Financial Statements
StemGen Financial Overview
StemGen's market cap is currently $4.57K. The company's EPS TTM is $0.00; its P/E ratio is -10.53; StemGen has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 21 | Jun 20 | Jun 19 | Jun 18 | Jun 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 39.00K | $ 19.35K | $ 22.06K | $ 0.00 | $ 0.00 |
| Gross Profit | $ 8.55K | $ 10.78K | $ 13.55K | $ 0.00 | $ 0.00 |
| Operating Income | $ -244.00K | $ -67.07K | $ -243.00K | $ -32.33K | $ 7.55K |
| EBITDA | $ -179.87K | $ -70.60K | $ -308.00K | $ 0.00 | $ 7.55K |
| Net Income | $ -433.00K | $ -230.77K | $ -426.00K | $ 6.12K | $ -70.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.34K | $ 236.00 | $ 2.75K | $ 0.00 | $ 635.00 |
| Total Assets | $ 401.64K | $ 397.11K | $ 390.20K | $ 0.00 | $ 635.00 |
| Total Debt | $ 563.20K | $ 563.20K | $ 563.20K | $ 560.17K | $ 651.94K |
| Net Debt | $ 561.86K | $ 562.97K | $ 560.45K | $ 560.17K | $ 651.31K |
| Total Liabilities | $ 1.74M | $ 1.49M | $ 1.26M | $ 904.34K | $ 911.09K |
| Stockholders' Equity | $ -1.33M | $ -1.09M | $ -869.80K | $ -904.34K | $ -910.45K |
| Cash Flow | |||||
| Free Cash Flow | $ -141.20K | $ -36.52K | $ -105.09K | $ -8.13K | $ 7.55K |
| Operating Cash Flow | $ -141.20K | $ -36.52K | $ -105.09K | $ -8.13K | $ 7.55K |
| Investing Cash Flow | $ 22.50K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 119.80K | $ 34.01K | $ 87.82K | $ 7.50K | $ 0.00 |
Currency in USD